Pfizer And GlaxoSmithKline Joint Venture, ViiV Healthcare Presents Phase III Data at AIDS 2018 From GEMINI Studies Showing Two-Drug Regimen Of Dolutegravir And Lamivudine Has Similar Efficacy To Three-Drug Regimen In Treatment Of Naïve HIV Patient